Corcept Therapeutics (CORT)
Corcept Therapeutics (CORT) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- CORT last traded at $63.62 on 2026-11-20, -2.09% for the session.
- Corcept Therapeutics: market cap $6.96B, P/E 43.7, revenue $963.65M over the last four quarters.
- Over the past year CORT returned -16.40%, with a year-to-date return of 82.82%.